| 11254647 |
Benzo-fused heterocyclic derivatives useful as agonists of GPR120 |
Zhihua Sui |
2022-02-22 |
$192,742,000 |
| 10730847 |
Benzo-fused heterocyclic derivatives useful as agonists of GPR120 |
Zhihua Sui |
2020-08-04 |
$103,352,000 |
| 10155737 |
Benzo-fused heterocyclic derivatives useful as agonists of GPR120 |
Zhihua Sui |
2018-12-18 |
$201,471,000 |
| 9562053 |
Benzo-fused heterocyclic derivatives useful as agonists of GPR120 |
Zhihua Sui |
2017-02-07 |
$119,895,000 |
| 9434693 |
Substituted pyrazoles as N-type calcium channel blockers |
Mark Wall, Zhihua Sui, Christopher Flores |
2016-09-06 |
$91,731,000 |
| 9062048 |
Cyclohexyl-azetidinyl antagonists of CCR2 |
James C. Lanter, Thomas P. Markotan, Zhihua Sui |
2015-06-23 |
$67,203,000 |
| 8921559 |
4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of CCR2 |
James C. Lanter, Thomas P. Markotan, Zhihua Sui, Xuqing Zhang |
2014-12-30 |
$83,373,000 |
| 8901314 |
Substituted pyrazoles as N-type calcium channel blockers |
Mark Wall, Zhihua Sui, Christopher Flores |
2014-12-02 |
$62,938,000 |
| 8518969 |
Cyclohexyl-azetidinyl antagonists of CCR2 |
James C. Lanter, Thomas P. Markotan, Zhihua Sui |
2013-08-27 |
$41,522,000 |
| 7868023 |
Thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
Shelley K. Ballentine, Jeremy Travins, Ehab M. Khalil, Farah Ali, Kristi A. Leonard +4 more |
2011-01-11 |
$56,292,000 |
| 7482376 |
Conjugated complement cascade inhibitors |
Ehab M. Khalil, Farah Ali, Heather Rae Hufnagel, Shelley K. Ballentine, Jeremy Travins +2 more |
2009-01-27 |
|
| 7385066 |
Thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
Shelley K. Ballentine, Jeremy Travins, Ehab M. Khalil, Farah Ali, Kristi A. Leonard +4 more |
2008-06-10 |
$794,986,000 |
| 7138530 |
Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
Ehab M. Khalil, Kristi A. Leonard, Farah Ali, Heather Rae Hufnagel, Jeremy Travins +10 more |
2006-11-21 |
|
| 7109354 |
Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
Ehab M. Khalil, Kristi A. Leonard, Farah Ali, Heather Rae Hufnagel, Jeremy Travins +10 more |
2006-09-19 |
|
| 6562840 |
Heteroaryl amidines, methylamidines and guanidines, and the use thereof as protease inhibitors |
Carl R. Illig, James B. Hoffman, Kenneth Wilson, M. Jonathan Rudolph, Juan Jose Marugan |
2003-05-13 |
|
| 6515002 |
Compounds and compositions for treating C1s-mediated diseases and conditions |
Carl R. Illig, James B. Hoffman, Kenneth Wilson, M. Jonathan Rudolph, Roger F. Bone +2 more |
2003-02-04 |
$1,659,000 |
| 6492403 |
Methods of treating C1s-mediated diseases and conditions and compositions thereof |
Carl R. Illig, James B. Hoffman, Kenneth Wilson, M. Jonathan Rudolph, Roger F. Bone +2 more |
2002-12-10 |
$1,010,000 |
| 6403633 |
Heteroaryl amidines, methylamidines and guanidines, and use thereof as protease inhibitors |
Carl R. Illig, James B. Hoffman, Kenneth Wilson, M. Jonathan Rudolph, Juan Jose Marugan |
2002-06-11 |
$1,705,000 |
| 6291514 |
Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors |
Carl R. Illig, James B. Hoffman, Kenneth Wilson, M. Jonathan Rudolph, Juan Jose Marugan |
2001-09-18 |
$1,406,000 |
| 6127191 |
Aminobenzenedicarboxylic acid-based combinatorial libraries |
Todd L. Graybill, Zhengdong Wu, Cynthia L. Fedde, Joseph M. Salvino |
2000-10-03 |
$20,581,000 |
| 5792769 |
Guanidino protease inhibitors |
Tianbao Lu, Carl R. Illig, Bruce E. Tomczuk, Richard Soll, Roger F. Bone |
1998-08-11 |
|
| 5741819 |
Arylsulfonylaminobenzene derivatives and the use thereof as factor Xa inhibitors |
Carl R. Illig, Richard Soll, Joseph M. Salvino, Bruce E. Tomczuk, Tianbao Lu |
1998-04-21 |
|
| 5612369 |
Thrombin inhibitors |
Roger F. Bone, Richard Soll, Carl L. Illig, Tianbao Lu |
1997-03-18 |
|
| 5359087 |
Bioactive quisqualic acid analogs |
Rodney L. Johnson, James F. Koerner |
1994-10-25 |
|
